头孢他啶-阿维巴坦联合氨曲南对耐碳青霉烯肺炎克雷伯菌体外增效敏感性及生物膜抑制机制研究。

IF 4 2区 生物学 Q2 MICROBIOLOGY
Frontiers in Microbiology Pub Date : 2025-03-20 eCollection Date: 2025-01-01 DOI:10.3389/fmicb.2025.1542029
Guangfen Wang, Hui Zhang, Qiaoping Wu, Jianqiang Xu, Xuedan Qiu, Jinyuan Chen, Fujie Cui, Jian Zhou, Qingcao Li
{"title":"头孢他啶-阿维巴坦联合氨曲南对耐碳青霉烯肺炎克雷伯菌体外增效敏感性及生物膜抑制机制研究。","authors":"Guangfen Wang, Hui Zhang, Qiaoping Wu, Jianqiang Xu, Xuedan Qiu, Jinyuan Chen, Fujie Cui, Jian Zhou, Qingcao Li","doi":"10.3389/fmicb.2025.1542029","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>This study aims to investigate the synergistic effects and biofilm inhibition mechanisms of ceftazidime-avibactam (CZA) combined with aztreonam (ATM) against carbapenem-resistant <i>Klebsiella pneumoni</i>a (CRKP) commonly found in the local clinical setting, providing new insights for clinical anti-infective strategies.</p><p><strong>Methods: </strong>We selected a total of 150 non-duplicate clinical isolates of CRKP from multiple hospitals in Ningbo. Common carbapenemase genes were detected using PCR. Broth microdilution and time-kill assays were used to evaluate the <i>in vitro</i> synergistic effects of CZA and ATM, both individually and in combination, on CRKP isolates with different enzyme types, and the fractional inhibitory concentration index (FICI) was calculated. The crystal violet staining method and bacterial cell permeability assay were employed to assess the impact of CZA, ATM, and their combination on the cell structure and biofilm formation capacity of CRKP. Real-time quantitative PCR (qRT-PCR) was used to measure the expression levels of biofilm-related genes (<i>Luxs</i>, <i>mrkA</i>, <i>wbbM</i>, <i>pgaA</i>, and <i>wzm</i>) in CRKP under treatment with CZA, ATM, or their combination.</p><p><strong>Results: </strong>The comparison of synergistic indices for different enzyme-type CRKP strains with CZA and ATM combination therapy showed a statistically significant difference (<i>p</i> < 0.01). The time-kill assay indicated that the time-kill curves for strains carrying <i>blaKPC-2</i> and <i>blaNDM-1</i> resistance genes were similar between the monotherapy and combination therapy groups, while the CZA + ATM combination therapy group showed a significant decrease in bacterial concentration after 4-8 h of cultivation compared to the CZA and ATM monotherapy groups. The crystal violet staining and bacterial cell permeability assays demonstrated that the CZA + ATM combination significantly reduced biofilm formation and increased cellular structure disruption in CRKP. The qRT-PCR results showed that CZA combined with ATM notably decreased the expression levels of biofilm-related genes <i>Luxs</i>, <i>mrkA</i>, <i>wbbM</i>, <i>pgaA</i>, and <i>wzm</i> in CRKP.</p><p><strong>Conclusion: </strong>The combination of ATM and CZA shows a strong synergistic antibacterial effect against CRKP strains with various enzyme types, with particularly notable synergy in strains carrying the <i>blaKPC-2</i> resistance gene. Additionally, this combination significantly disrupts the cellular structure of CRKP and inhibits biofilm formation.</p>","PeriodicalId":12466,"journal":{"name":"Frontiers in Microbiology","volume":"16 ","pages":"1542029"},"PeriodicalIF":4.0000,"publicationDate":"2025-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11965359/pdf/","citationCount":"0","resultStr":"{\"title\":\"Study on the invitro synergistic susceptibility and biofilm inhibition mechanism of ceftazidime-avibactam combined with aztreonam against carbapenem-resistant <i>Klebsiella pneumoniae</i>.\",\"authors\":\"Guangfen Wang, Hui Zhang, Qiaoping Wu, Jianqiang Xu, Xuedan Qiu, Jinyuan Chen, Fujie Cui, Jian Zhou, Qingcao Li\",\"doi\":\"10.3389/fmicb.2025.1542029\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>This study aims to investigate the synergistic effects and biofilm inhibition mechanisms of ceftazidime-avibactam (CZA) combined with aztreonam (ATM) against carbapenem-resistant <i>Klebsiella pneumoni</i>a (CRKP) commonly found in the local clinical setting, providing new insights for clinical anti-infective strategies.</p><p><strong>Methods: </strong>We selected a total of 150 non-duplicate clinical isolates of CRKP from multiple hospitals in Ningbo. Common carbapenemase genes were detected using PCR. Broth microdilution and time-kill assays were used to evaluate the <i>in vitro</i> synergistic effects of CZA and ATM, both individually and in combination, on CRKP isolates with different enzyme types, and the fractional inhibitory concentration index (FICI) was calculated. The crystal violet staining method and bacterial cell permeability assay were employed to assess the impact of CZA, ATM, and their combination on the cell structure and biofilm formation capacity of CRKP. Real-time quantitative PCR (qRT-PCR) was used to measure the expression levels of biofilm-related genes (<i>Luxs</i>, <i>mrkA</i>, <i>wbbM</i>, <i>pgaA</i>, and <i>wzm</i>) in CRKP under treatment with CZA, ATM, or their combination.</p><p><strong>Results: </strong>The comparison of synergistic indices for different enzyme-type CRKP strains with CZA and ATM combination therapy showed a statistically significant difference (<i>p</i> < 0.01). The time-kill assay indicated that the time-kill curves for strains carrying <i>blaKPC-2</i> and <i>blaNDM-1</i> resistance genes were similar between the monotherapy and combination therapy groups, while the CZA + ATM combination therapy group showed a significant decrease in bacterial concentration after 4-8 h of cultivation compared to the CZA and ATM monotherapy groups. The crystal violet staining and bacterial cell permeability assays demonstrated that the CZA + ATM combination significantly reduced biofilm formation and increased cellular structure disruption in CRKP. The qRT-PCR results showed that CZA combined with ATM notably decreased the expression levels of biofilm-related genes <i>Luxs</i>, <i>mrkA</i>, <i>wbbM</i>, <i>pgaA</i>, and <i>wzm</i> in CRKP.</p><p><strong>Conclusion: </strong>The combination of ATM and CZA shows a strong synergistic antibacterial effect against CRKP strains with various enzyme types, with particularly notable synergy in strains carrying the <i>blaKPC-2</i> resistance gene. Additionally, this combination significantly disrupts the cellular structure of CRKP and inhibits biofilm formation.</p>\",\"PeriodicalId\":12466,\"journal\":{\"name\":\"Frontiers in Microbiology\",\"volume\":\"16 \",\"pages\":\"1542029\"},\"PeriodicalIF\":4.0000,\"publicationDate\":\"2025-03-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11965359/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Frontiers in Microbiology\",\"FirstCategoryId\":\"99\",\"ListUrlMain\":\"https://doi.org/10.3389/fmicb.2025.1542029\",\"RegionNum\":2,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"MICROBIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Microbiology","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.3389/fmicb.2025.1542029","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

目的:探讨头孢他啶-阿维巴坦(CZA)联合氨曲南(ATM)对当地临床常见病碳青霉烯耐药肺炎克雷伯菌(CRKP)的协同作用及生物膜抑制机制,为临床抗感染策略提供新的见解。方法:选取宁波市多家医院临床分离的CRKP非重复株共150株。PCR检测常见碳青霉烯酶基因。采用微量肉汤稀释法和时间杀伤法评价CZA和ATM单独或联合对不同酶型的CRKP分离株的体外协同作用,并计算分数抑制浓度指数(FICI)。采用结晶紫染色法和细菌细胞通透性实验评估CZA、ATM及其组合对CRKP细胞结构和生物膜形成能力的影响。采用实时定量PCR (Real-time quantitative PCR, qRT-PCR)检测CZA、ATM或两者联合处理下CRKP中生物膜相关基因(Luxs、mrkA、wbbM、pgaA、wzm)的表达水平。结果:CZA和ATM联合治疗对不同酶型CRKP菌株的增效指标比较,差异有统计学意义(p 单药组与联合治疗组blaKPC-2和blaNDM-1耐药基因相似,而CZA + ATM联合治疗组培养4-8 h后细菌浓度较CZA和ATM单药组显著降低。结晶紫染色和细菌细胞通透性实验表明,CZA + ATM组合显著减少了CRKP中生物膜的形成,增加了细胞结构的破坏。qRT-PCR结果显示,CZA联合ATM显著降低了CRKP中生物膜相关基因Luxs、mrkA、wbbM、pgaA、wzm的表达水平。结论:ATM与CZA联合用药对多种酶型的CRKP菌株均有较强的协同抑菌作用,其中对携带blaKPC-2耐药基因的菌株的协同抑菌作用尤为显著。此外,这种组合显著破坏了CRKP的细胞结构,抑制了生物膜的形成。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Study on the invitro synergistic susceptibility and biofilm inhibition mechanism of ceftazidime-avibactam combined with aztreonam against carbapenem-resistant Klebsiella pneumoniae.

Objective: This study aims to investigate the synergistic effects and biofilm inhibition mechanisms of ceftazidime-avibactam (CZA) combined with aztreonam (ATM) against carbapenem-resistant Klebsiella pneumonia (CRKP) commonly found in the local clinical setting, providing new insights for clinical anti-infective strategies.

Methods: We selected a total of 150 non-duplicate clinical isolates of CRKP from multiple hospitals in Ningbo. Common carbapenemase genes were detected using PCR. Broth microdilution and time-kill assays were used to evaluate the in vitro synergistic effects of CZA and ATM, both individually and in combination, on CRKP isolates with different enzyme types, and the fractional inhibitory concentration index (FICI) was calculated. The crystal violet staining method and bacterial cell permeability assay were employed to assess the impact of CZA, ATM, and their combination on the cell structure and biofilm formation capacity of CRKP. Real-time quantitative PCR (qRT-PCR) was used to measure the expression levels of biofilm-related genes (Luxs, mrkA, wbbM, pgaA, and wzm) in CRKP under treatment with CZA, ATM, or their combination.

Results: The comparison of synergistic indices for different enzyme-type CRKP strains with CZA and ATM combination therapy showed a statistically significant difference (p < 0.01). The time-kill assay indicated that the time-kill curves for strains carrying blaKPC-2 and blaNDM-1 resistance genes were similar between the monotherapy and combination therapy groups, while the CZA + ATM combination therapy group showed a significant decrease in bacterial concentration after 4-8 h of cultivation compared to the CZA and ATM monotherapy groups. The crystal violet staining and bacterial cell permeability assays demonstrated that the CZA + ATM combination significantly reduced biofilm formation and increased cellular structure disruption in CRKP. The qRT-PCR results showed that CZA combined with ATM notably decreased the expression levels of biofilm-related genes Luxs, mrkA, wbbM, pgaA, and wzm in CRKP.

Conclusion: The combination of ATM and CZA shows a strong synergistic antibacterial effect against CRKP strains with various enzyme types, with particularly notable synergy in strains carrying the blaKPC-2 resistance gene. Additionally, this combination significantly disrupts the cellular structure of CRKP and inhibits biofilm formation.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
7.70
自引率
9.60%
发文量
4837
审稿时长
14 weeks
期刊介绍: Frontiers in Microbiology is a leading journal in its field, publishing rigorously peer-reviewed research across the entire spectrum of microbiology. Field Chief Editor Martin G. Klotz at Washington State University is supported by an outstanding Editorial Board of international researchers. This multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信